Just Released
|
||
The Latest Ebola Outbreak: What’s Different about the U.S. and
International Response?
The United States
played a leading role in the international response to the 2014 Ebola
outbreak in West Africa, providing the most financial support, mobilizing
U.S. staff across the federal government, and jumpstarting international
efforts to strengthen global health security. As this month’s new outbreak
unfolds in the Democratic Republic of Congo (DRC), the U.S. so far is playing
a more limited role.
A new Kaiser Family Foundation brief examines key
differences and changes since 2014 that are shaping how the U.S. and
international community are responding in the DRC. These differences include:
While the current outbreak is in its early stages,
the brief notes that the U.S. has been somewhat quicker to join the
international response than in 2014. Multiple U.S. agencies, including the
Centers for Disease Control and Prevention (providing epidemiological and
laboratory support) and USAID (providing technical assistance such as mobile
laboratories), are involved – though largely in a supporting role.
The brief also explores the U.S. budget for global
health response efforts, including the Trump Administration’s May 8 request
for Congress to rescind $252 million in remaining Ebola funds authorized in
2014 but not yet spent.
Filling
the need for trusted information on national health issues, the
Kaiser Family Foundation is a nonprofit organization based in San Francisco,
California.
|
||
|
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Tuesday, May 29, 2018
The Latest Ebola Outbreak: What’s Different about the U.S. and International Response?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment